Ara
Toplam kayıt 3, listelenen: 1-3
Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome
(Taylor & Francis Ltd, 2014)
Objective. the aim of this study was to compare the serum levels of fibroblast growth factor 21 (FGF-21) between patients with polycystic ovary syndrome (PCOS) and control subjects and to assess the possible relation with ...
Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease
(Elsevier Sci Ltd, 2014)
This study investigated serum paraoxonase (PON1) and arylesterase activity along with determination of oxidative status via measurement of total oxidant status (TOS), total anti-oxidant status (TAS) and oxidative stress ...
Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
(E-Century Publishing Corp, 2014)
Pentraxin-3 (PTX3) a cytokine-inducible molecule is released from various tissues. Its level increases as a response to different inflammatory conditions. Polycystic Ovary Syndrome (PCOS) is considered as a proinflammatory ...